Nuveen Asset Management, LLC Zynerba Pharmaceuticals, Inc. Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$3.31 - $6.54 $362,590 - $716,417	-109,544 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$2.9 - $6.16 $771 - $1,638	-266 Reduced 0.24%	109,544 $0
Q4 2019 Feb 14, 2020	SELL	$5.61 - $8.57 $44,896 - $68,585	-8,003 Reduced 6.79%	109,810 $664,000
Q3 2019 Nov 14, 2019	BUY	$7.56 - $15.44 $430,761 - $879,755	56,979 Added 93.66%	117,813 $891,000
Q2 2019 Aug 15, 2019	BUY	$5.4 - $15.5 $328,503 - $942,927	60,834 New	60,834 $824,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.